Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726798 | SCV000703097 | pathogenic | not provided | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000593032 | SCV000799983 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2018-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000593032 | SCV001413368 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-04-14 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp168*) in the CAPN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant has not been reported in the literature in individuals affected with CAPN3-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 498205). |
Baylor Genetics | RCV003459465 | SCV004213826 | likely pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2022-09-17 | flagged submission | clinical testing |